This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Assistance Publique-Hopitaux De Paris, National Institute of Health and Medical Research, Sorbonne Université. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023
Title: Xavier Waintraub: Innovator in Cardiac Treatment
Introduction
Xavier Waintraub is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the treatment of cardiac conditions. His innovative approach has led to the development of a unique method for addressing wave burst arrhythmia.
Latest Patents
Waintraub holds 1 patent for his invention titled "Steroidal hormones for the treatment and prevention of wave burst arrhythmia." This invention focuses on a new method for preventing and treating wave burst arrhythmia by administering a gestagen that has an androgenic effect. This advancement has the potential to improve patient outcomes in cardiac health.
Career Highlights
Throughout his career, Waintraub has worked with esteemed organizations such as Assistance Publique-Hôpitaux de Paris and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to collaborate with leading experts in the medical field.
Collaborations
Waintraub has collaborated with notable professionals, including Joe-Elie Salem and Christian Funck-Brentano. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Xavier Waintraub's contributions to the field of cardiac treatment through his innovative patent demonstrate his commitment to improving healthcare. His work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile